Direct-acting antiviral therapy for hepatitis C: The initial experience of the University of Cape Town/Groote Schuur Hospital Liver Clinic, South Africa.
CONCLUSIONS: DAA therapy for HCV in a pan-genotypic group of patients, many with advanced liver disease, was highly effective. Our outcomes correspond with existing trial and real-world data for similar treatment. DAA therapy and access need rapid upscaling in SA, especially targeting key populations at point of care.
PMID: 32657680 [PubMed - as supplied by publisher]
Source: South African Medical Journal - Category: African Health Tags: S Afr Med J Source Type: research
More News: African Health | Antiviral Therapy | Cirrhosis | Hepatitis | Hepatitis C | Laboratory Medicine | Liver | Liver Disease | Norvir | South Africa Health | Urology & Nephrology | Virology | Women